Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 22 articles:
HTML format
Text format



Single Articles


    March 2017
  1. BANERJEE S, Zare RN, Tibshirani RJ, Kunder CA, et al
    Diagnosis of prostate cancer by desorption electrospray ionization mass spectrometric imaging of small metabolites and lipids.
    Proc Natl Acad Sci U S A. 2017 Mar 14. pii: 201700677.
    PubMed     Text format     Abstract available


    November 2016
  2. LORENZO G, Scott MA, Tew K, Hughes TJ, et al
    Tissue-scale, personalized modeling and simulation of prostate cancer growth.
    Proc Natl Acad Sci U S A. 2016 Nov 16. pii: 201615791.
    PubMed     Text format     Abstract available


    October 2016
  3. FERRARA F, Staquicini DI, Driessen WH, D'Angelo S, et al
    Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer.
    Proc Natl Acad Sci U S A. 2016 Oct 24. pii: 201615400.
    PubMed     Text format     Abstract available


    September 2016
  4. STOYANOVA T, Riedinger M, Lin S, Faltermeier CM, et al
    Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer.
    Proc Natl Acad Sci U S A. 2016 Sep 30. pii: 201614529.
    PubMed     Text format     Abstract available


  5. ALHASAN AH, Scott AW, Wu JJ, Feng G, et al
    Circulating microRNA signature for the diagnosis of very high-risk prostate cancer.
    Proc Natl Acad Sci U S A. 2016 Sep 6. pii: 201611596.
    PubMed     Text format     Abstract available


    June 2016
  6. AHMAD I, Mui E, Galbraith L, Patel R, et al
    Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer.
    Proc Natl Acad Sci U S A. 2016 Jun 29. pii: 201601571.
    PubMed     Text format     Abstract available


  7. RAINA K, Lu J, Qian Y, Altieri M, et al
    PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer.
    Proc Natl Acad Sci U S A. 2016 Jun 6. pii: 201521738.
    PubMed     Text format     Abstract available


    May 2016
  8. KOMURA K, Jeong SH, Hinohara K, Qu F, et al
    Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression.
    Proc Natl Acad Sci U S A. 2016 May 16. pii: 201600420.
    PubMed     Text format     Abstract available


    April 2016
  9. PARK JW, Lee JK, Phillips JW, Huang P, et al
    Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay.
    Proc Natl Acad Sci U S A. 2016;113:4482-7.
    PubMed     Text format     Abstract available


    March 2016
  10. SYKES EA, Dai Q, Sarsons CD, Chen J, et al
    Tailoring nanoparticle designs to target cancer based on tumor pathophysiology.
    Proc Natl Acad Sci U S A. 2016;113:E1142-51.
    PubMed     Text format     Abstract available


    February 2016
  11. HOSOYA H, Dobroff AS, Driessen WH, Cristini V, et al
    Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release.
    Proc Natl Acad Sci U S A. 2016;113:1877-82.
    PubMed     Text format     Abstract available


    January 2016
  12. FENG FY, Kothari V
    Driven to metastasize: Kinases as potential therapeutic targets in prostate cancer.
    Proc Natl Acad Sci U S A. 2016 Jan 8. pii: 201522938.
    PubMed     Text format    


  13. LINCH SN, Kasiewicz MJ, McNamara MJ, Hilgart-Martiszus IF, et al
    Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice.
    Proc Natl Acad Sci U S A. 2016 Jan 4. pii: 201510518.
    PubMed     Text format     Abstract available


    November 2015
  14. FALTERMEIER CM, Drake JM, Clark PM, Smith BA, et al
    Functional screen identifies kinases driving prostate cancer visceral and bone metastasis.
    Proc Natl Acad Sci U S A. 2015 Nov 30. pii: 201521674.
    PubMed     Text format     Abstract available


  15. ELLIS L, Loda M
    Advanced neuroendocrine prostate tumors regress to stemness.
    Proc Natl Acad Sci U S A. 2015;112:14406-7.
    PubMed     Text format    


  16. FEHR D, Veeraraghavan H, Wibmer A, Gondo T, et al
    Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images.
    Proc Natl Acad Sci U S A. 2015;112:E6265-E6273.
    PubMed     Text format     Abstract available


  17. COSTA HA, Leitner MG, Sos ML, Mavrantoni A, et al
    Discovery and functional characterization of a neomorphic PTEN mutation.
    Proc Natl Acad Sci U S A. 2015;112:13976-81.
    PubMed     Text format     Abstract available


    October 2015
  18. SMITH BA, Sokolov A, Uzunangelov V, Baertsch R, et al
    A basal stem cell signature identifies aggressive prostate cancer phenotypes.
    Proc Natl Acad Sci U S A. 2015 Oct 12. pii: 201518007.
    PubMed     Text format     Abstract available


    July 2015
  19. SCAFOGLIO C, Hirayama BA, Kepe V, Liu J, et al
    Functional expression of sodium-glucose transporters in cancer.
    Proc Natl Acad Sci U S A. 2015;112:E4111-9.
    PubMed     Text format     Abstract available


  20. HONDA S, Loher P, Shigematsu M, Palazzo JP, et al
    Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers.
    Proc Natl Acad Sci U S A. 2015;112:E3816-25.
    PubMed     Text format     Abstract available


  21. HUANG SX, Yun BS, Ma M, Basu HS, et al
    Leinamycin E1 acting as an anticancer prodrug activated by reactive oxygen species.
    Proc Natl Acad Sci U S A. 2015;112:8278-83.
    PubMed     Text format     Abstract available


    June 2015
  22. SALAMEH A, Lee AK, Cardo-Vila M, Nunes DN, et al
    PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.
    Proc Natl Acad Sci U S A. 2015 Jun 15. pii: 201507882.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: